| Tech Consultant Hylaine Presents at the Digital Insurance Summit on Building and Unifying Data, and Scaling Insurance Operations in the Cloud |
Globe Newswire |
05/11 |
08:00 |
| Enterprise AI Is Stalling: 46% of Initiatives Fall Short Despite Rising Investment |
Globe Newswire |
05/11 |
08:00 |
| eXp World Holdings Reports Q1 2026 Results |
Globe Newswire |
05/11 |
07:45 |
| Inspira Technologies CEO Issues Letter to Shareholders on Strategic Direction and Value Creation Plan |
Globe Newswire |
05/11 |
07:31 |
| Intellia Therapeutics Announces First Quarter 2026 Financial Results and Business Updates |
Globe Newswire |
05/11 |
07:30 |
| Onex Announces An “Event of Change” Affecting the Voting Rights of Its Multiple and Subordinate Voting Share Classes |
Globe Newswire |
05/11 |
07:30 |
| Cronos Group Reports 2026 First Quarter Results |
Globe Newswire |
05/11 |
07:30 |
| Dyne Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights |
Globe Newswire |
05/11 |
07:30 |
| Bicara Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
05/11 |
07:30 |
| Alterity Therapeutics Announces Publication Demonstrating the Utility of Quantitative MRI as a Biomarker for Multiple System Atrophy |
Globe Newswire |
05/11 |
07:25 |
| Tapbit Enhances Platform Reliability with Advanced Asset Protection and Transparency Framework |
Globe Newswire |
05/11 |
07:16 |
| Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination |
Globe Newswire |
05/11 |
07:01 |
| IREN Announces Proposed Convertible Notes Offering |
Globe Newswire |
05/11 |
07:00 |
| OTC Markets Group Welcomes Evolve Royalties Ltd. to OTCQX |
Globe Newswire |
05/11 |
07:00 |
| Hain Celestial Reports Fiscal Third Quarter 2026 Financial Results |
Globe Newswire |
05/11 |
07:00 |
| Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program |
Globe Newswire |
05/11 |
07:00 |
| Keel Infrastructure Reports First Quarter 2026 Results |
Globe Newswire |
05/11 |
07:00 |
| Village Farms Reports Q1 2026 Results Driven by Record International Export Sales |
Globe Newswire |
05/11 |
07:00 |
| Erasca Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA® (Pembrolizumab) |
Globe Newswire |
05/11 |
07:00 |
| OutSolve CEO to Speak on State & Federal Employment Regulations at Gartner CHRO Executive Summit in Minnesota |
Globe Newswire |
05/11 |
07:00 |
| MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing |
Globe Newswire |
05/11 |
07:00 |
| Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update |
Globe Newswire |
05/11 |
07:00 |
| Coppernico Advances Multi-Kilometre Tipicancha Copper-Gold Target Ahead of Initial Drilling |
Globe Newswire |
05/11 |
07:00 |
| OTC Markets Group Welcomes Grande Portage Resources Ltd. to OTCQX |
Globe Newswire |
05/11 |
07:00 |
| Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes |
Globe Newswire |
05/11 |
07:00 |
